These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1028 related articles for article (PubMed ID: 33312177)
1. Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia. Griggio V; Perutelli F; Salvetti C; Boccellato E; Boccadoro M; Vitale C; Coscia M Front Immunol; 2020; 11():594556. PubMed ID: 33312177 [TBL] [Abstract][Full Text] [Related]
2. NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications. Sportoletti P; De Falco F; Del Papa B; Baldoni S; Guarente V; Marra A; Dorillo E; Rompietti C; Adamo FM; Ruggeri L; Di Ianni M; Rosati E Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206399 [TBL] [Abstract][Full Text] [Related]
3. Novel Therapies in Chronic Lymphocytic Leukemia: A Rapidly Changing Landscape. Iovino L; Shadman M Curr Treat Options Oncol; 2020 Mar; 21(4):24. PubMed ID: 32170458 [TBL] [Abstract][Full Text] [Related]
4. T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword. Vlachonikola E; Stamatopoulos K; Chatzidimitriou A Front Immunol; 2020; 11():612244. PubMed ID: 33552073 [TBL] [Abstract][Full Text] [Related]
6. Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic Leukemia. Hofland T; Eldering E; Kater AP; Tonino SH Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31484424 [TBL] [Abstract][Full Text] [Related]
7. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment. Hallek M Am J Hematol; 2019 Nov; 94(11):1266-1287. PubMed ID: 31364186 [TBL] [Abstract][Full Text] [Related]
8. Chimeric Antigen Receptor T Cells in Chronic Lymphocytic Leukemia: Are We Any Closer to a Cure? Rhodes JM; Schuster SJ Cancer J; 2019; 25(6):436-441. PubMed ID: 31764125 [TBL] [Abstract][Full Text] [Related]